Safety, immunogenicity and dose ranging of a new Vi-CRM₁₉₇ conjugate vaccine against typhoid fever: randomized clinical testing in healthy adults von van Damme, Pierre, Kafeja, Froukje, Anemona, Alessandra, Basile, Venere, Hilbert, Anne Katrin, De Coster, Ilse, Rondini, Simona, Micoli, Francesca, Qasim Khan, Rana M, Marchetti, Elisa, Di Cioccio, Vito, Saul, Allan, Martin, Laura B, Podda, Audino

Volltext

Vedolizumab, Adalimumab, and Methotrexate Combination Therapy in Crohn’s Disease (EXPLORER) von Colombel, Jean-Frederic, Ungaro, Ryan C., Sands, Bruce E., Siegel, Corey A., Wolf, Douglas C., Valentine, John F., Feagan, Brian G., Neustifter, Blue, Kadali, Harisha, Nazarey, Pradeep, James, Alexandra, Jairath, Vipul, Qasim Khan, Rana M.

Volltext

Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observ... von Bhutta, Zulfiqar A, Prof, Capeding, Maria Rosario, MD, Bavdekar, Ashish, MD, Marchetti, Elisa, PhD, Ariff, Shabina, MD, Soofi, Sajid B, MD, Anemona, Alessandra, MSc, Habib, Muhammad A, MD, Alberto, Edison, MD, Juvekar, Sanjay, MD, Khan, Rana M Qasim, MD, Marhaba, Rachid, PhD, Ali, Noshad, MD, Malubay, Nelia, MD, Kawade, Anand, MD, Saul, Allan, PhD, Martin, Laura B, PhD, Podda, Audino, Dr

Volltext

ENTERPRET: A Randomized Controlled Trial of Vedolizumab Dose Optimization in Patients With Ulcerative Colitis Who Have Early Nonresponse von Jairath, Vipul, Yarur, Andres, Osterman, Mark T., James, Alexandra, Balma, Diane, Mehrotra, Shailly, Yang, Lili, Yajnik, Vijay, Qasim Khan, Rana M.

Volltext

Incidence of suboptimal response to tumor necrosis factor antagonist therapy in inflammatory bowel disease in newly industrialised countries: The EXPLORE study von Yamamoto-Furusho, Jesus K., Al Harbi, Othman, Armuzzi, Alessandro, Chan, Webber, Ponce de Leon, Enrique, Qian, Jiaming, Shapina, Marina, Toruner, Murat, Tu, Chia-Hung, Ye, Byong Duk, Guennec, Morgane, Sison, Cecilia, Demuth, Dirk, Fadeeva, Olga, Khan, Qasim M. Rana

Volltext

Clinical Trial Design in Ulcerative Colitis: Interpreting Evolving Endpoints Based on Post Hoc Analyses of the Vedolizumab Phase 3 Trials GEMINI 1 and VISIBLE 1 von Sandborn, William J, Sands, Bruce E, Uddin, Sharif, Qasim Khan, Rana M, Sagar Mukherjee, Richa

Volltext

P432 Barriers to prescribing anti-TNF therapy in inflammatory bowel disease (IBD) across newly industrialised emerging market countries: an analysis of the ‘EXPLORE’ study von Ye, B D, Yamamoto Furusho, J K, Rana Qasim Khan, M, Fadeeva, O, Demuth, D, Qian, J, Khalif, I L, Chia-Hung, T, Toruner, M, Othman, A H, Chan, W, Ponce de Leon, E, Guennec, M, Sison, C, Uberti Foppa, E, Armuzzi, A

Volltext

Safety, Immunogenicity and Dose Ranging of a New Vi-CRM.sub.197 Conjugate Vaccine against Typhoid Fever: Randomized Clinical Testing in Healthy Adults von van Damme, Pierre, Kafeja, Froukje, Anemona, Alessandra, Basile, Venere, Hilbert, Anne Katrin, De Coster, Ilse, Rondini, Simona, Micoli, Francesca, Qasim Khan, Rana M, Marchetti, Elisa, Di Cioccio, Vito, Saul, Allan, Martin, Laura B, Podda, Audino

Volltext

Effects of Sr-substitution on the structural and magnetic behavior of Ba-based Y-type hexagonal ferrites von Ahmad, Mukhtar, Ali, Qasim, Ali, Ihsan, Ahmad, Ishtiaq, Azhar Khan, M., Akhtar, Majid Niaz, Murtaza, G., Rana, M.U.

Volltext

Tu1741 EFFICACY AND SAFETY OUTCOMES IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS STRATIFIED BY ETHNICITY AND RACE: A POOLED ANALYSIS OF DATA FROM GEMINI 1, VARSITY, AND V... von Mukherjee, Richa S., Khan, Qasim Rana, Liu, Julia J., Ananthakrishnan, Ashwin, Lichtenstein, Gary R., Uddin, Sharif M., Young, Lisa, Boules, Mena, Adamson, Paula, Reeves, Vonda

Volltext

Outcomes and Adverse Effects of Transcatheter Aortic Valve Replacement (TAVR) in Cancer Patients: A Meta-Analysis von Ahsan, Umar, Naz, Samia, Anum, Aroba, Unum, Amara, Hamza, Rana M, Qasim, Rana M, Taaruf, Ansub, Khan, Nishat

Volltext